Home > National Drug Code (NDC) > Irbesartan and Hydrochlorothiazide

Irbesartan and Hydrochlorothiazide - 68180-413-09 - (Irbesartan and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Irbesartan and Hydrochlorothiazide

Product NDC: 68180-413
Proprietary Name: Irbesartan and Hydrochlorothiazide
Non Proprietary Name: Irbesartan and Hydrochlorothiazide
Active Ingredient(s): 12.5; 150    mg/1; mg/1 & nbsp;   Irbesartan and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Irbesartan and Hydrochlorothiazide

Product NDC: 68180-413
Labeler Name: Lupin Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA201524
Marketing Category: ANDA
Start Marketing Date: 20130404

Package Information of Irbesartan and Hydrochlorothiazide

Package NDC: 68180-413-09
Package Description: 90 TABLET, FILM COATED in 1 BOTTLE (68180-413-09)

NDC Information of Irbesartan and Hydrochlorothiazide

NDC Code 68180-413-09
Proprietary Name Irbesartan and Hydrochlorothiazide
Package Description 90 TABLET, FILM COATED in 1 BOTTLE (68180-413-09)
Product NDC 68180-413
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Irbesartan and Hydrochlorothiazide
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20130404
Marketing Category Name ANDA
Labeler Name Lupin Pharmaceuticals, Inc.
Substance Name HYDROCHLOROTHIAZIDE; IRBESARTAN
Strength Number 12.5; 150
Strength Unit mg/1; mg/1
Pharmaceutical Classes Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]

Complete Information of Irbesartan and Hydrochlorothiazide


General Information